We report a case of cellulitis caused by a novel Cupriavidus species identified using whole-genome sequence analysis. Subcutaneous tissue biopsies from the left lower leg of a 67-year-old man who suffered from cellulitis were cultured. Round, convex, gray and non-hemolytic colonies were recovered after 72-h incubation. 16S rRNA sequence analysis showed 98.6% similarity with Cupriavidus basilensis DSM 11853(T) in the NCBI database and 99.9% similarity with C. basilensis KF708 in the EzBioCloud database. Genomic analysis using the MiSeq platform (Illumina, USA) and the TrueBac ID database (ChunLab, Korea) revealed that the average nucleotide identity (ANI) of this strain with C. basilensis DSM 11853(T) was 87.6%. The patient was treated with oral cefditoren pivoxil for 9 weeks. This study is the first to report cellulitis caused by Cupriavidus species strain J1218. (Ann Clin Microbiol 2019;22:105 -109)
INTRODUCTION
Cupriavidus is a genus of aerobic gram-negative glucose-nonfermenting bacillus common in the environment but rarely isolated from clinical specimens. Clinical manifestations of infection with Cupriavidus species are varied and include pneumonia, bacteremia, meningitis, and septicemia in children [1] [2] [3] .
Muscular abscess in a renal transplant recipient and airway infection with a Cupriavidus species in patients with cystic fibrosis suggest that immunodeficiency may be a prior condition for infection by this genus [3] [4] [5] [6] [7] .
We describe the first case of class II cellulitis in an immunocompetent patient caused by a novel Cupriavidus species identified using whole-genome sequencing.
CASE REPORT
A 67-year-old man complained of fever, redness, swelling, and pain in his left lower leg for 2 weeks; the lesion did not respond to antibiotic therapy. He had no underlying disease other than benign prostatic hyperplasia. He was often exposed to freshwater during fishing and gardening. Erythema remained after 10 days of intravenous and oral ceftriaxone treatment.
Intravenous and oral levofloxacin treatment was then given for 6 weeks, but the lesion persisted. A magnetic resonance imaging (MRI) scan with enhancement of the lower leg revealed prominent swelling of the cutaneous and subcutaneous layer and non-enhancing fluid in the mid-to distal calf. Tissue was obtained from the lower leg via ultrasound-guided biopsy for bacterial and acid-fast bacterial culture. Round, convex, gray, non-hemolytic colonies were visible on BAP agar after 72 h incubation at 35°C ( Fig. 1 ). Vitek MS IVD v3.0 (bioMérieux, Manchester, UK) failed to identify these colonies, while the Grinstead, UK) to yield AST data for up to 72 h, taking into account the slow growth characteristics of this strain. However, the minimum inhibitory concentration (MIC) of ciprofloxacin was still less than 0.06 μg/mL (Table 1) . Finally, the patient was successfully treated with a 9-week course of oral cefditoren pivoxil.
DISCUSSION
The criteria for prokaryotic species circumscription are traditionally defined as a DNA-DNA hybridization (DDH) value of at least 70% similarity, and a temperature within 5°C of the thermal denaturation midpoint [8] . Recently, 16S rRNA sequence similarity of less than 98.7%, and ANI values of 95-96% or a digital DDH of less than 70%, were proposed as criteria for classifying new species based on whole-genome sequencing data [9, 10] . A recent study found that 12% of bacteria prospectively collected from intensive care units in a tertiary care hospital during 1 year were novel genomospecies, according to pairwise ANI analysis using BLAST [11] .
In this study, we were unable identify this isolate using Vitek MS despite repeated tests. The Vitek 2 system identified this isolate as C. pauculus, which was included in the Vitek MS v3.0 library. We performed 16S rRNA sequencing analysis to determine the reason for the discrepancy between the Vitek 2 system and Vitek MS. Cupriavidus species are known to be difficult to identify by biochemical tests, making molecular assays necessary for accurate identification of this genus [4] . [13] . In the same study, C. basilensis strain KF708 was reclassified as Cupriavidus sp. by a combination of phylogenetic analyses and whole-genome sequence analyses [13] . Genomic analysis revealed that the strain investigated in the current study was a novel Cupriavidus species.
Whole-genome sequencing data of this strain showed 100% identity of carA, ErmE, Brucella suis mprF and OXA-63 genes.
Also, it had an adeF gene with 75-76% similarity and the gene was associated with fluoroquinolone resistance with efflux pumps. The AST results for Cupriavidus strain J1218 showed that it is susceptible to all antibiotic agents according to the CLSI guideline M100 [14] . Since differences can exist between genetic and phenotypic data, further study is needed on the relationship between the AST and whole-genome sequencing data.
Patients infected with Cupriavidus species are usually immunocompromised [2, 3, 5, 7] . Cases of infection with this genus have also been reported in elderly patients without obvious immunodeficiency [15, 16] . The patient in the present study was immunocompetent, but had experienced frequent injuries to the lower limbs. The patient underwent sustained antimicrobial treatment and the lesion was completely healed after 6 months.
In conclusion, we identified a novel Cupriavidus sp. strain, J1218, using 16S rRNA-based molecular analyses and whole-genome sequencing. This is the first reported case of cellulitis caused by a novel Cupriavidus sp. strain J1218 requiring long-term antibiotic therapy in an immunocompetent patient.
